132 related articles for article (PubMed ID: 23797229)
1. 99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO).
Jing H; Li F; Zhong D; Zhuang H
Clin Nucl Med; 2013 Aug; 38(8):664-7. PubMed ID: 23797229
[TBL] [Abstract][Full Text] [Related]
2. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.
Jin X; Jing H; Li F; Zhuang H
Clin Nucl Med; 2013 Nov; 38(11):922-4. PubMed ID: 24089059
[TBL] [Abstract][Full Text] [Related]
3. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
[TBL] [Abstract][Full Text] [Related]
4. Increased Uptake of Brown Tumor in 99m Tc-HYNIC-TOC Scintigraphy Mimicking Postoperative Recurrence of Tumor-Induced Osteomalacia.
Zhang Y; Wang P; Liu M; Liu Y; Jing H
Clin Nucl Med; 2023 Nov; 48(11):978-979. PubMed ID: 37703478
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-HYNIC-TOC in the Evaluation of Recurrent Tumor-Induced Osteomalacia.
Shi X; Jing H; Li F; Zhao Y; Wang Z; Huo L
Clin Nucl Med; 2019 Mar; 44(3):209-213. PubMed ID: 30672760
[TBL] [Abstract][Full Text] [Related]
6. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report.
Garcia CA; Spencer RP
Clin Nucl Med; 2002 Aug; 27(8):582-3. PubMed ID: 12170004
[TBL] [Abstract][Full Text] [Related]
7. [Value of
Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
[TBL] [Abstract][Full Text] [Related]
8. Breast Carcinoma Shown on 99mTc-HYNIC-TOC Study Performed to Evaluate Tumor-Induced Osteomalacia.
Jin X; Li F; Chen L; Jing H
Clin Nucl Med; 2022 Feb; 47(2):197-199. PubMed ID: 34406185
[TBL] [Abstract][Full Text] [Related]
9. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of
Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
12. Detection of recurrent pancreatic primitive neuroectodermal tumor by tc-99m hydrazinonicotinyl-tyr3-octreotide scan.
Jing H; Li F; Chen L; Zhang T; Zhao Y
Clin Nucl Med; 2011 Jan; 36(1):54-5. PubMed ID: 21157213
[TBL] [Abstract][Full Text] [Related]
13. Cardiac pheochromocytomas detected by Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) scintigraphy.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
Clin Nucl Med; 2007 Mar; 32(3):182-5. PubMed ID: 17314591
[TBL] [Abstract][Full Text] [Related]
14. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
[TBL] [Abstract][Full Text] [Related]
16. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hyperplasia shown on (99m)Tc-HYNIC-TOC scan.
Niu N; Mao X; Jing H; Li F
Clin Nucl Med; 2013 Apr; 38(4):294-6. PubMed ID: 23455537
[TBL] [Abstract][Full Text] [Related]
18. [99mTc-OCTREOTIDE in patients with neuroendocrine tumors from the GI tract].
Gómez M; Ferrando R; Vilar J; Hitateguy R; López B; Moreira E; Kapitán M; De Lima F; Agüero B; Gabriela Villegas M; Urdaneta N; Gutiérrez E; Battegazzore A; Bayardo K; Silveira A; Lago G; Páez A
Acta Gastroenterol Latinoam; 2010 Dec; 40(4):332-8. PubMed ID: 21381408
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
20. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
Korde A; Mallia M; Shinto A; Sarma HD; Samuel G; Banerjee S
Cancer Biother Radiopharm; 2014 Nov; 29(9):387-94. PubMed ID: 25379612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]